BioCorRx Inc. (BICX)

Every figure this model derived for BICX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2022-12-31
cash 21,237 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 623,377 AssetsCurrent 2026-06-30
current liabilities 8,854,703 LiabilitiesCurrent 2026-06-30
equity -12,224,836 StockholdersEquity 2026-06-30
interest expense 160,770 InterestExpense 2026-06-30
ocf -2,355,429 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 797,244 Revenues 2025-12-31
sbc 516,266 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up BICX on one particular measure came for.

RatioValue
cash operating margin-548.46
current ratio0.07
current ratio reported0.07
deferred revenue growth-98.16
dilution pct76.72
fcf margin-295.45
growth cv1.97
interest cover-30.49
operating margin-614.78
owner earnings margin-360.2
revenue growth10301.1
revenue growth per share5785.49
rule of 409686.31
sbc pct revenue64.76

What to be careful about

What this model itself distrusts about BICX's figures. Written by the derivation as it ran, not added afterwards.